Sign in
8-K/A

Current Report

Larimar Therapeutics, Inc. Filed Acc 0001193125-20-291777

Exhibits

  • Item 9.01 Financial statements and exhibits

From the SEC's structured data for this filing

Loading d37478d8ka.htm…